Company / Free Cash Flow
Evolent Health, Inc. Free Cash Flow History
FY2016-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$78.2M
FY2019
5-year range
-
FY2016-FY2019
Trend
-29.9%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow has declined for 3 consecutive years, from -$51M in FY2016 to -$78M in FY2019.
Based on SEC 10-K filings.
-$78M in FY2019.
Declined from -$56M to -$78M over the past 2 years.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Evolent Health, Inc.'s free cash flow has declined for 3 consecutive years.
- In FY2019, free cash flow decreased 29.9% year-over-year.
Company context
Key Data Points
- Altman Z-Score -0.84 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | -$78.2M | -29.9% |
| FY2018 | -$60.2M | -7.9% |
| FY2017 | -$55.8M | -9.3% |
| FY2016 | -$51.0M | -104.3% |
As of FY2019 · SEC Form 10-K · Last checked Jun 21, 2026